British animal genetics company Genus expects to report full-year adjusted pretax profit "moderately above" the upper end of current market expectations, sending its shares as much as 15.3% higher on ...

Last September, Basingstoke-based Genus struck a deal to accelerate its 49%-owned porcine joint venture with BCA in China.

Following this strong performance, Genus now anticipates its full-year 2026 adjusted profit before tax to be moderately above the top end of current market expectations, which range from £82.7 million ...

The Basingstoke, England-based animal biotechnology and genetics company said adjusted pretax profit for the six months to December 31 will be about GBP50 million, ahead of expectations. It will be ...

To get a sense of who is truly in control of Genus plc (LON:GNS), it is important to understand the ownership structure of the business. The group holding the most number of shares in the company, ...

Genus PLC (GENSF) achieved strong financial results with a 30% increase in group adjusted operating profit in constant currency. The company reported a significant milestone with the US FDA approval ...

Genus is listed in the FTSE All-Share, FTSE 350 Low Yield, FTSE 250, FTSE 350 indices. Genus is listed in the Medicine and Biotech sector. Genus Plc Ord 10p is listed on the London Stock Exchange ...